Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia
- 1 December 1991
- journal article
- case report
- Published by Elsevier in The Journal of Pediatrics
- Vol. 119 (6), 985-989
- https://doi.org/10.1016/s0022-3476(05)83063-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapyThe Lancet, 1991
- Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemiaThe Lancet, 1990
- Pharmacogenetics of acute azathioprine toxicity: Relationship to thiopurine methyltransferase genetic polymorphismClinical Pharmacology & Therapeutics, 1989
- The purine path to chemotherapyIn Vitro Cellular & Developmental Biology, 1989
- ARE CHILDREN WITH LYMPHOBLASTIC LEUKAEMIA GIVEN ENOUGH 6-MERCAPTOPURINE?The Lancet, 1987
- Thiopurine pharmacogenetics in leukemia: Correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrationsClinical Pharmacology & Therapeutics, 1987
- Assay of 6-thioinosinic acid and 6-thioguanine nucleotides, active metabolites of 6-mercaptopurine, in human red blood cellsJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- Childhood leukaemia: a relationship between intracellular 6‐ mercaptopurine metabolites and neutropenia.British Journal of Clinical Pharmacology, 1983
- Thiopurine methyltransferase biochemical genetics: Human lymphocyte activityBiochemical Genetics, 1982
- Human erythrocyte thiopurine methyltransferase: Radiochemical microassay and biochemical propertiesClinica Chimica Acta; International Journal of Clinical Chemistry, 1978